ASX FY26 presentation: record revenue growth offset by technology costs

ASX surged 11.85% to $62.09 after reporting FY26 operating revenue of $1.25B (+13.3% YoY) alongside underlying NPAT of $536.4M (+5.2%). Profitability was pressured by elevated investment spending and regulatory remediation, with EBITDA margin down 180bps to 61.0% and statutory NPAT down 3.5% to $484.9M due to $51.5M after-tax one-offs (including $30.8M ASIC Inquiry costs). FY27 expenses guidance is reconfirmed at +18–21% (or +13–16% excluding depreciation/amortization), with FY27 capex of $180–200M.

Analysis

This looks less like a clean earnings breakout and more like a repricing of regulatory and execution risk. For an exchange monopoly, the key variable is not just revenue growth but whether investors believe the “cleanup” phase is nearing completion; if so, the equity can re-rate even while reported margins are still pressured by modernization spend. Near term, the beneficiaries are mostly the IT/cloud and consulting ecosystem feeding the transformation, while the more important second-order winners are domestic brokers and banks if future settlement upgrades reduce collateral frictions and operating balance-sheet drag.

The main risk is that the market is extrapolating cyclical volume strength into a structural step-up in earnings power. Rate-volatility and cash-turnover revenues can cool within 1-2 quarters, but the cost base is sticky for 12-24 months, so there is a real chance FY27 looks like “good top line, disappointing operating leverage.” The thesis is falsified if expense growth tracks below guidance, the capital-release approval comes quickly, and no material tech slippage emerges; otherwise, the stock remains vulnerable to a narrative reset from “remediation almost done” to “multi-year build still underway.”

Contrarian view: the move may be partly overdone on relief. Consensus is focusing on higher trading activity, but the longer-duration issue is that the transformation cycle still has years left, and markets often underprice how long regulators keep a strategic discount in place. If management continues to execute without incident, the next leg is not volume-driven but multiple expansion on confidence that normalized ROE is durable and dividends remain protected.

Key Decisions for Investors

• Buy ASXFY only on a 3-5% pullback or after ASIC approves the capital-release package; target 6-12 months for 10-15% upside, with the thesis invalidated by a tech incident, guidance cut, or expense growth above the top end.
• For holders, sell 1-3 month covered calls against ASXFY to monetize the post-results pop while preserving medium-term upside tied to regulatory de-risking.
• If you want a cleaner relative-value expression, pair long ASXFY vs short CBOE or NDAQ into next quarter; the long benefits from de-risking and domestic monopoly optics, while the short is more exposed to valuation compression if volatility normalizes.
• Treat any FY27 capex revision above the current range as a red flag and reduce exposure; that would signal the transformation burden is still expanding rather than converging.